Analysis of clinical factors for the efficacy of TPF in treating hypopharyngeal carcinoma.
- Author:
Lianhe LI
;
Fuxian TAN
;
Wenhui YUE
;
Hongmei WANG
;
Hongmin WANG
;
Hao XUE
;
Zhenlei WEN
- Publication Type:Journal Article
- MeSH:
Antineoplastic Combined Chemotherapy Protocols;
therapeutic use;
Cisplatin;
therapeutic use;
Fluorouracil;
therapeutic use;
Humans;
Hypopharyngeal Neoplasms;
therapy;
Lymphatic Metastasis;
Retrospective Studies;
Taxoids;
therapeutic use;
Treatment Outcome
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2015;29(19):1705-1707
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To summarize the clinical effect of TPF regimen in the treatment of hypopharyngeal carcinoma and explore various clinical factors affecting treatment efficacy.
METHOD:The clinical data of 20 cases with hypopharyngeal carcinoma, who received TPF treatment, were analyzed retrospectively. After two courses of chemotherapy, based on radiographic outcomes, next treatment plan was developed. To sum up the clinical information, including the clinical type, patterns of tumor growth, pathologic type, tumor stage, lymph node metastasis, age and so on. To analyze possible influencing factors affecting curative effect.
RESULT:(1) After 20 cases with hypopharyngeal carcinoma received two courses of TPF treatment, the effect was evaluated. Objective response rate was 65%. (2) In patients with hypopharyngeal carcinoma, the efficacy of TPF therapy was significantly related to the clinical type, patterns of tumor growth and pathologic type; there was no statistical significance in tumor stage, lymph node metastasis and age.
CONCLUSION:According to the clinical type, patterns of tumor growth and pathologic type of hypopharyngeal carcinoma, resistance to chemotherapy in hypopharyngeal carcinoma can be assessed, which provides important basis for designing individualized treatment plan.
